HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by He, T. C. Articles by Wojchowski, D. M. Search for Related Content PubMed PubMed Citation Articles by He, T. C. Articles by Wojchowski, D. M. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 269, Issue 28, 18291-18294, 07, 1994

The extended box 2 subdomain of erythropoietin receptor is nonessential for Jak2 activation yet critical for efficient mitogenesis in FDC-ER cells

TC He, N Jiang, H Zhuang, DE Quelle and DM Wojchowski
Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park 16802.

The development of erythroid progenitor cells depends upon exposure to the glycoprotein hormone, erythropoietin (EPO). Binding of EPO to its transmembrane receptor leads to the rapid tyrosine phosphorylation of several cellular targets including Shc, Raf-1, Gap120, the cloned EPO receptor (EPOR), pp100/97, and a M(r) 130,000 EPO-activated receptor- associated Janus protein tyrosine kinase, Jak2. A membrane-proximal cytosolic region of the EPOR recently has been shown to be essential for the activation of Jak2 and sufficient for EPO-induced mitogenesis. This cytosolic region includes 8-12 amino acid box 1 and box 2 subdomains, which are conserved in certain class I receptors as well as a more distal 10-40 amino acid subdomain (extended box 2 subdomain, ExBx2), which likewise is implicated in mitogenic signaling. Through the expression of EPOR carboxyl-terminal truncation mutants in FDC-P1 cells, we presently show that an EPOR form truncated within the ExBx2 domain efficiently activates Jak2, yet is deficient in mitogenesis. Efficient expression of this mutant receptor at the cell surface and its ability to activate Jak2 indicate that poor mitogenic activity does not result from aberrant transport or folding. Rather, failure of this mutant to support proliferation above nominal rates underlines an apparent role for the EPOR ExBx2 subdomain in the activation of a distinct primary mitogenic effector.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Usacheva, R. Sandoval, P. Domanski, S. V. Kotenko, K. Nelms, M. A. Goldsmith, and O. R. Colamonici Contribution of the Box 1 and Box 2 Motifs of Cytokine Receptors to Jak1 Association and Activation J. Biol. Chem., December 6, 2002; 277(50): 48220 - 48226. [Abstract] [Full Text] [PDF]

				A. Usacheva, S. Kotenko, M. M. Witte, and O. R. Colamonici Two Distinct Domains Within the N-Terminal Region of Janus Kinase 1 Interact with Cytokine Receptors J. Immunol., August 1, 2002; 169(3): 1302 - 1308. [Abstract] [Full Text] [PDF]

				G. Bahrenberg, I. Behrmann, A. Barthel, P. Hekerman, P. C. Heinrich, H.-G. Joost, and W. Becker Identification of the Critical Sequence Elements in the Cytoplasmic Domain of Leptin Receptor Isoforms Required for Janus Kinase/Signal Transducer and Activator of Transcription Activation by Receptor Heterodimers Mol. Endocrinol., April 1, 2002; 16(4): 859 - 872. [Abstract] [Full Text] [PDF]

				K. Fujio, T. Nosaka, T. Kojima, T. Kawashima, T. Yahata, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, K. Yamamoto, T. Nishimura, et al. Molecular cloning of a novel type 1 cytokine receptor similar to the common gamma chain Blood, April 1, 2000; 95(7): 2204 - 2210. [Abstract] [Full Text] [PDF]

				W.-P. Chang, Y. Ye, and C. V. Clevenger Stoichiometric Structure-Function Analysis of the Prolactin Receptor Signaling Domain by Receptor Chimeras Mol. Cell. Biol., February 1, 1998; 18(2): 896 - 905. [Abstract] [Full Text]

				F. Verdier, S. Chretien, C. Billat, S. Gisselbrecht, C. Lacombe, and P. Mayeux Erythropoietin Induces the Tyrosine Phosphorylation of Insulin Receptor Substrate-2. AN ALTERNATE PATHWAY FOR ERYTHROPOIETIN-INDUCED PHOSPHATIDYLINOSITOL 3-KINASE ACTIVATION J. Biol. Chem., October 17, 1997; 272(42): 26173 - 26178. [Abstract] [Full Text] [PDF]

				P. Domanski, E. Fish, O. W. Nadeau, M. Witte, L. C. Platanias, H. Yan, J. Krolewski, P. Pitha, and O. R. Colamonici A Region of the beta  Subunit of the Interferon alpha  Receptor Different from Box 1 Interacts with Jak1 and Is Sufficient to Activate the Jak-Stat Pathway and Induce an Antiviral State J. Biol. Chem., October 17, 1997; 272(42): 26388 - 26393. [Abstract] [Full Text] [PDF]

				M. Socolovsky, I. Dusanter-Fourt, and H. F. Lodish The Prolactin Receptor and Severely Truncated Erythropoietin Receptors Support Differentiation of Erythroid Progenitors J. Biol. Chem., May 30, 1997; 272(22): 14009 - 14012. [Abstract] [Full Text] [PDF]

				B. Joneja and D. M. Wojchowski Mitogenic Signaling and Inhibition of Apoptosis via the Erythropoietin Receptor Box-1 Domain J. Biol. Chem., April 25, 1997; 272(17): 11176 - 11184. [Abstract] [Full Text] [PDF]

				S. M. Jacobs-Helber, K. Penta, Z. Sun, A. Lawson, and S. T. Sawyer Distinct Signaling from Stem Cell Factor and Erythropoietin in HCD57 Cells J. Biol. Chem., March 14, 1997; 272(11): 6850 - 6853. [Abstract] [Full Text] [PDF]

				S. T. Sawyer and K. Penta Association of JAK2 and STAT5 with Erythropoietin Receptors. ROLE OF RECEPTOR PHOSPHORYLATION IN ERYTHROPOIETIN SIGNAL TRANSDUCTION J. Biol. Chem., December 13, 1996; 271(50): 32430 - 32437. [Abstract] [Full Text] [PDF]

				N. Jiang, T.-C. He, A. Miyajima, and D. M. Wojchowski The box1 Domain of the Erythropoietin Receptor Specifies Janus Kinase 2Activation and Functions Mitogenically within an Interleukin 2beta -Receptor Chimera J. Biol. Chem., July 12, 1996; 271(28): 16472 - 16476. [Abstract] [Full Text] [PDF]

				P. A. Tilbrook, T. Bittorf, S. J. Busfield, D. Chappell, and S. P. Klinken Disrupted Signaling in a Mutant J2E Cell Line That Shows Enhanced Viability, but Does Not Proliferate or Differentiate, with Erythropoietin J. Biol. Chem., February 16, 1996; 271(7): 3453 - 3459. [Abstract] [Full Text] [PDF]

				R. H. Hackett, Y.-D. Wang, and A. C. Larner Mapping of the Cytoplasmic Domain of the Human Growth Hormone Receptor Required for the Activation of Jak2 and Stat Proteins J. Biol. Chem., September 8, 1995; 270(36): 21326 - 21330. [Abstract] [Full Text] [PDF]

				I. Sakai, L. Nabell, and A. S. Kraft Signal Transduction by a CD16/CD7/Jak2 Fusion Protein J. Biol. Chem., August 4, 1995; 270(31): 18420 - 18427. [Abstract] [Full Text] [PDF]

				H. Zhuang, Z. Niu, T.-C. He, S. V. Patel, and D. M. Wojchowski Erythropoietin-dependent Inhibition of Apoptosis Is Supported by Carboxyl-truncated Receptor Forms and Blocked by Dominant-negative Forms of Jak2 J. Biol. Chem., June 16, 1995; 270(24): 14500 - 14504. [Abstract] [Full Text] [PDF]